The Clinical and Translational Research Institute (CTRI) is part of a national
Clinical and Translational Science Award (CTSA) consortium, led by the
National Institutes of HealthNational Center for Advancing Translational Sciences (NCATS). Established in 2010, CTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. CTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,300 members. The
CTRI News and Funding Opportunities is a monthly newsletter.
CTRI Special Announcements
Photo by: Paul Turang
Occupancy of ACTRI Building Nears Completion
About 80 percent of the groups moving into the Altman Clinical and Translational Research Institute (ACTRI) building are now using their new offices, research labs and clinical research space. The moves are expected to be completed in early February, 2017. The building creates a unique, multidisciplinary environment that brings together laboratory scientists and clinical investigators to understand disease, develop new methods of treatment and translate clinical research results into clinical practice.
UC CAI Invites Applications for NHLBI Tech Grants
Letters of Intent Due November 18, 2016
UC CAI Invites Applications for NHLBI Stimulus Grants
Submissions Due Now-November 23, 2016
CTRI Seeks Applications for KL2 Training Support for Junior Faculty
Deadline November 29, 2016
CTRI and IEM Invite Applications for 2017 Galvanizing Engineering in Medicine (GEM) Awards
Phase I (Open to Clinically Active UC San Diego Faculty)
Deadline December 16, 2016
CTRI Vouchers for CTRI Research Services (In-kind)
CCBB Vouchers Recently Added
Eligible: Unfunded Projects Designed to Gather Preliminary Data for Grant Submissions or CTRI Pilot Projects Career Development Awards (K-series only; UC San Diego only) and CTRI KL2 Awardees
NCATS Open Funding Opportunities
CTRI News and Features
CTRI-Supported Pediatrics Researcher Tremoulet, MD, Makes an Impact on the Lives of Children with Kawasaki Disease
Her intentions for a career in medicine were shaped early, as a child. She always knew her focus would be pediatrics. While completing her master’s in clinical research, one of her mentors introduced her to Kawasaki disease. Today, Adriana Tremoulet, MD, is the associate director of the Kawasaki Disease Research Center at UC San Diego. In this role, she cares for nearly 1,500 children with Kawasaki disease in San Diego County and an additional 90 children a year hospitalized at Rady Children's Hospital-San Diego. Kawasaki disease (KD), an acute, self-limited vasculitis in childhood, is the leading cause of acquired heart disease in children in the United States and Japan. In 2013, Tremoulet, a pediatrician and pediatrics researcher, received support from the Clinical and Translational Research Institute (CTRI) for a pilot project to study why some children with KD do not respond to standard treatment.
UC San Diego Graduate Students Bring the Sparkle of GEM to Preuss Students
The Galvanizing Engineering in Medicine (GEM) program has launched a series of monthly talks at the Preuss School with the goal of inspiring the next generation of scientists. GEM, a program supported by UC San Diego Altman Clinical and Translational Research Institute (ACTRI) and UC San Diego Institute of Engineering in Medicine (IEM), brings engineers and clinicians together to develop innovative technology solutions to challenging problems in medical care. In the talk series, UC San Diego graduate students share research highlights from GEM projects with Preuss students. “We are really excited about bringing scientific discoveries to life for Preuss students through this new series,” said Priya Bisarya (pictured above), who spearheaded the cross-functional initiative between IEM and the ACTRI education unit. “This amazing program also helps create role models for these students, who are underrepresented in STEM (science, technology, engineering and math)."
ACTRI Hosts First Life Course Research Seminar and Workshop
Leaders and participants from the Life Course Research Seminar and Workshop gathered at the ACTRI auditorium on October 25. Photo by: Kyle Dykes.
UC San Diego Altman Clinical and Translational Research Institute (ACTRI) hosted a two-day seminar on life course research October 24-25 at the new ACTRI building. Led by Diana Kuh, PhD, a world-renowned expert in life course epidemiology, the event drew about 60 academic participants from across the U.S. and U.K. and featured about a dozen speakers, panelists and workshop facilitators. Life course research investigates the long-term effects of social, behavioral and biologic determinants of disease across the life span or across generations. ACTRI has created a “center” for life course research to incorporate special populations and all age groups into research. It is the first of its kind at UC San Diego and brings together pediatricians, neonatologists, internists, family medicine physicians and geriatrics specialists to study special populations and life course transitions. The center organized the symposium. “Life course research is a novel approach that is incredibly important as we look at health across the lifespan,” said Christina Chambers, PhD, MPH, director of the ACTRI Center for Life Course Research. “We were delighted that Dr. Kuh, one of the preeminent researchers in this field, could lead our first interactive life course seminar and workshop.”
In This Issue
CTRI Hosts Communications Seminar for Early Career “K” Awardees
The Clinical and Translational Research Institute (CTRI) is hosting a year-long career development seminar series, “Communicating: Your Academic Life Depends on It,” for early career “K” awardees from UC San Diego, San Diego State University, and CTRI partner institutions. The sixth session in the series is scheduled for Tuesday, December 6. Colin Depp, PhD, will present “Structuring a Scientific Talk.” The session will take place at the Altman CTRI building, specific room TBD. RSVP is required to
SAVE THE DATE! Special Inaugural Seminar by Dr. J. Craig Venter at ACTRI January 18
“Human Genomics and the Future of Medicine” will be presented by J. Craig Venter, PhD, on Wednesday, January 18, 2017, at 3 p.m. at the ACTRI building. Dr. Venter is co-founder, executive chairman, and CEO of Human Longevity, Inc.; co-founder, chairman, and co-chief scientific officer of Synthetic Genomics, Inc.; and founder, chairman, and CEO of J. Craig Venter Institute.
Cite the Grant
Don’t forget to cite the grant!.
To help ensure resources are available for future research,
please cite the UCSD CTRI CTSA grant.
Projects and Publications using UCSD CTRI resources must cite the UCSD CTRI grant and follow the NIH Public Access Policy.
CTRI News and Funding Opportunities
Gary S. Firestein, MD
Director of CTRI
Chief Administrative Officer